KARLIN DANIEL (Chief Medical Officer) sold 2.0% of their position (10.04K shares) of DEFINIUM THERAPEUTICS, INC. on the open market
Open‑market sale worth $451.9K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 6/26/2026ACC: 0001193125-26-285564
Officer· Chief Medical Officer
Since Jan 2022
-10.04K
Net shares
Net seller
$451.9K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
10.04K disposed
Non-Derivative Transactions1
Common Shares
Direct
Shares
−10.04K
Price / share
$45.03
Trade value
$451.88K
% of position
2.0%
6/25/2026
513.32K→503.28K
Total
Net shares
−10.04K
Net value
-$451.88K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Shares Direct | 6/25/2026 | S · Sale | −10.04K | $45.03 | $451.88K | 2.0% | 513.32K | 503.28K |
| Total | −10.04K | -$451.88K | ||||||
Derivative Transactions0
No derivative transactions reported